Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

STAAR Surgical Co (NASDAQ:STAA)

8.06
Delayed Data
As of Aug 27
 +0.28 / +3.60%
Today’s Change
4.84
Today|||52-Week Range
11.88
-11.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$309.7M

Company Description

STAAR Surgical Co. designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye. It is also a maker of lenses used worldwide in corrective or refractive surgery, and also makes lenses for use in surgery that treats cataracts. The company's principal products include Minimally Invasive Intraocular Lenses and Implantable Collamer Lenses. The intraocular lenses are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts, and include the company's lines of silicone and Collamer IOLs and the Preloaded Injector. The company's implantable collamer lenses consists of Visian ICL and TICL, which are intraocular lenses used to correct refractive conditions, such as myopia, hyperopia and astigmatism. STAAR Surgical was founded in 1982 and is headquartered in Monrovia, CA.

Contact Information

STAAR Surgical Co.
1911 Walker Avenue
Monrovia California 91016
P:(626) 303-7902
Investor Relations:

Employees

Shareholders

Other institutional47.21%
Mutual fund holders35.32%
Individual stakeholders24.47%

Top Executives

Caren L. MasonPresident, Chief Executive Officer & Director
Hans-Martin BlickensdoerferPresident-International Commercial Operations
Stephen P. BrownChief Financial Officer & Vice President
Jon HayashidaVice President-Medical Affairs & Global Clinical
Keith HollidayVice President-Research & Development